Josef Yayan,Karl-Josef Franke,Melanie Berger et al.
Josef Yayan et al.
Tuberculosis remains a significant global health challenge. Tuberculosis affects millions of individuals worldwide. Early detection of tuberculosis plays a relevant role in the management of treatment of tuberculosis. This systematic review...
Obtaining patient phenotypes in SARS-CoV-2 pneumonia, and their association with clinical severity and mortality [0.03%]
获得SARS-CoV-2肺炎患者的表型及其与临床严重性和死亡率的关系
Fernando García-García,Dae-Jin Lee,Mónica Nieves-Ermecheo et al.
Fernando García-García et al.
Background: There exists consistent empirical evidence in the literature pointing out ample heterogeneity in terms of the clinical evolution of patients with COVID-19. The identification of specific phenotypes underlying ...
Back to the future: the novel art of digital auscultation applied in a prospective observational study of critically ill Covid-19 patients [0.03%]
重返未来：一项在重症新冠患者中开展的前瞻性观察研究中的数字听诊新实践
Evangelos Kaimakamis,Serafeim Kotoulas,Myrto Tzimou et al.
Evangelos Kaimakamis et al.
Background: The Covid-19 pandemic has caused immense pressure on Intensive Care Units (ICU). In patients with severe ARDS due to Covid-19, respiratory mechanics are important for determining the severity of lung damage. L...
Invasive pulmonary aspergillosis among patients with severe community-acquired pneumonia and influenza in ICUs: a retrospective cohort study [0.03%]
重症社区获得性肺炎和流感患者ICU病房侵袭性肺曲霉病的回顾性队列研究
Wei-Chun Lee,Che-Chia Chang,Meng-Chin Ho et al.
Wei-Chun Lee et al.
Rationale: The prevalence, clinical characteristics, and outcomes of invasive pulmonary aspergillosis in patients with severe community-acquired pneumonia (CAP) in intensive care units remain underestimated because of the...
Accuracy of the recording of pneumonia events in English electronic healthcare record data in patients with chronic obstructive pulmonary disease [0.03%]
慢性阻塞性肺疾病患者中电子健康记录数据中肺炎事件记录的准确性
Alexander J Adamson,Constantinos Kallis,Ian Douglas et al.
Alexander J Adamson et al.
Background: In primary care, identifying pneumonia events in people with chronic obstructive pulmonary disease (COPD) may be challenging due to similarities in symptoms with COPD exacerbations and lack of diagnostic testi...
Pneumonic-type lung adenocarcinoma with KRAS G12V mutation and sustained response to Afatinib [0.03%]
携带KRAS G12V突变的类肺炎型肺腺癌对艾氟尼布表现良好
Jie Zhao,Jiachen Xu,Tian Qiu et al.
Jie Zhao et al.
Background: Pneumonic-type lung adenocarcinoma (P-ADC) is a rare and challenging subtype of primary lung cancer that can be difficult to distinguish from pneumonia based on radiological images. Furthermore, no drugs are c...
Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions? [0.03%]
应考虑选择性使用预防药物来防止引起肺炎的肺囊虫感染疑似病例出现麻风反应吗？
Nuria Ramírez-Perea,Claudia Moran-Castaño,Jose A Perez-Molina
Nuria Ramírez-Perea
Leprosy reactions often require prolonged high-dose steroids or immunosuppressive drugs, putting patients at risk of Pneumocystis jirovecii pneumonia (PJP). However, no PJP cases are reported, possibly due to dapsone treatment for leprosy. ...
Sex-dependent vulnerability for Wistar rats model following intranasal instillation with Klebsiella pneumoniae ATCC 43816 causing lobar pneumonia [0.03%]
鼻内给予肺炎克雷伯菌（ATCC 43816）诱导的大鼠肺脓肿性别依赖性易感性研究模型效应毒性试验
Patrick Hervé Diboue Betote,Esther Del Florence Ndedi Moni,Sonia Raïssa Gayap Matchuenkam et al.
Patrick Hervé Diboue Betote et al.
Background: Klebsiella pneumoniae has become one of the major threats to public health as it causes nosocomial and community-acquired infections like lobar pneumonia. This infection causes acute inflammation in the lung, ...
Combination of a multiplex pneumonia panel and Gram staining for antimicrobial selection to treat lower respiratory tract infection [0.03%]
多重肺炎面板和革兰氏染色的结合用于下呼吸道感染的抗菌选择
Hiroshi Matsuura,Koudai Arimoto,Yoshihito Takahashi et al.
Hiroshi Matsuura et al.
Aim: This study aimed to examine the utility of simultaneously performed the Film Array pneumonia panels (pneumonia panels) and Gram staining with the same specimens and evaluate their effect on antimicrobial selection. ...
Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID) [0.03%]
法维拉韦在COVID-19肺炎患者中的安全性和有效性。一项随机、双盲、安慰剂对照研究(FAVID)
Juan P Horcajada,Rebeca Aldonza,Mónica Real et al.
Juan P Horcajada et al.
Purpose: To design a randomized clinical trial to assess the efficacy and safety of favipiravir in patients with COVID-19 disease with pneumonia. Methods:...